Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

2.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

3.

Racial differences seen in epigenetic age acceleration in childhood cancer survivors

4.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

5.

For elderly, unfit patients, the all-oral AML regimen shows promise.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot